United States Biotechnology & Medical Research

Abcellera Biologics Inc (ABCL)

Track

Abcellera Biologics Inc. has seen no insider trading activity within the last three months. The most recent recorded transaction occurred on May 14, 2026, when John S. Montalbano purchased 20,000 shares. Historical data indicates a consistent pattern of buying by various stakeholders, including Thermopylae Holdings Ltd. and company executives, over previous periods.
Ticker: ABCL Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Abcellera Biologics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 14 Aug 2026
Value US$1,347,233.95 | Price 314.37 | Shares 58,409 (+45.9%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-14 2026-08-14 B Purchase
4.1
Booth Andrew

Chief Financial Officer

Officer
58,409 +45.9%
314.37
US$1,347,234 		58,409 +45.9% 314.37 US$1,347,234
2026-08-14 2026-08-12 B Purchase
3.1
Hayden Michael R
Non-Executive Director
50,145 -17.0%
301.17
US$553,574 		50,145 -17.0% 301.17 US$553,574
2026-05-18 2026-05-14 B Purchase
3.3
Montalbano John S.
Non-Executive Director
48,860 +29.9%
157.91
US$3,134,208 		48,860 +29.9% 157.91 US$3,134,208
2026-03-02 2026-02-27 B Purchase
4.3
Thermopylae Holdings Ltd.
Large shareholder
38,000 +0.1%
3.44
US$130,720 		38,000 +0.1% 3.44 US$130,720
2026-02-27 2026-02-27 B Purchase
4.1
Booth Andrew

Chief Financial Officer

Officer
42,600 +27.8%
3.42
US$145,692 		42,600 +27.8% 3.42 US$145,692
2026-02-27 2026-02-26 B Purchase
4.3
Thermopylae Holdings Ltd.
Large shareholder
177,457 +0.3%
3.27
US$580,284 		177,457 +0.3% 3.27 US$580,284
2025-11-26 2025-11-26 B Purchase
3.3
Montalbano John S.
Non-Executive Director
50,000 +29.2%
3.57
US$178,460 		50,000 +29.2% 3.57 US$178,460
2025-03-11 2025-03-11 B Purchase
4.3
Thermopylae Holdings Ltd.
Large shareholder
343,631 +0.6%
2.16
US$742,243 		343,631 +0.6% 2.16 US$742,243
2025-03-10 2025-03-10 B Purchase
3.3
Montalbano John S.
Non-Executive Director
25,000 +17.1%
2.30
US$57,500 		25,000 +17.1% 2.30 US$57,500
2025-03-07 2025-03-06 B Purchase
3.3
Montalbano John S.
Non-Executive Director
60,000 +69.8%
2.34
US$140,568 		60,000 +69.8% 2.34 US$140,568
2024-08-29 2024-08-29 B Purchase
4.3
Thermopylae Holdings Ltd.
Large shareholder
283,516 +0.5%
2.61
US$739,977 		283,516 +0.5% 2.61 US$739,977
2023-11-08 2023-11-08 B Purchase
3.3
Montalbano John S.
Non-Executive Director
10,000 +13.2%
4.46
US$44,600 		10,000 +13.2% 4.46 US$44,600
2023-11-08 2023-11-06 B Purchase
3.3
Montalbano John S.
Non-Executive Director
20,000 +35.7%
4.64
US$92,800 		20,000 +35.7% 4.64 US$92,800
2023-09-26 2023-09-22 B Purchase
3.1
Hayden Michael R
Non-Executive Director
20,000 +1.5%
4.91
US$98,200 		20,000 +1.5% 4.91 US$98,200
2023-09-14 2023-09-12 B Purchase
3.9
Lecault Veronique

Chief Operating Officer

Executive Director
20,000 +1.0%
5.19
US$103,800 		20,000 +1.0% 5.19 US$103,800
2023-08-09 2023-08-08 B Purchase
3.1
Hayden Michael R
Non-Executive Director
30,000 +2.4%
5.90
US$177,000 		30,000 +2.4% 5.90 US$177,000
2023-05-26 2023-05-26 B Purchase
4.1
Booth Andrew

Chief Financial Officer

Officer
14,500 +10.5%
6.85
US$99,325 		14,500 +10.5% 6.85 US$99,325
2023-05-26 2023-05-26 B Purchase
4.3
Thermopylae Holdings Ltd.
Large shareholder
153,000 +0.3%
6.52
US$997,728 		153,000 +0.3% 6.52 US$997,728
2022-12-20 2022-12-16 B Purchase
4.3
Thermopylae Holdings Ltd.
Large shareholder
85,102 +0.2%
10.10
US$859,249 		85,102 +0.2% 10.10 US$859,249
2022-08-22 2022-08-19 B Purchase
4.3
Thermopylae Holdings Ltd.
Large shareholder
200,000 +0.4%
11.46
US$2,292,460 		200,000 +0.4% 11.46 US$2,292,460
2022-06-15 2022-06-14 B Purchase
4.3
Thermopylae Holdings Ltd.
Large shareholder
9,173 +0.0%
8.05
US$73,842 		9,173 +0.0% 8.05 US$73,842
2022-06-15 2022-06-13 B Purchase
4.3
Thermopylae Holdings Ltd.
Large shareholder
54,915 +0.1%
8.03
US$441,066 		54,915 +0.1% 8.03 US$441,066
2022-06-08 2022-06-06 B Purchase
4.3
Thermopylae Holdings Ltd.
Large shareholder
64,545 +0.1%
7.50
US$483,965 		64,545 +0.1% 7.50 US$483,965
2022-05-17 2022-05-16 B Purchase
3.9
Lecault Veronique

Chief Operating Officer

Executive Director
200,000 +12.7%
6.34
US$1,267,780 		200,000 +12.7% 6.34 US$1,267,780
2022-05-17 2022-05-13 B Purchase
4.3
Thermopylae Holdings Ltd.
Large shareholder
300,000 +0.5%
7.26
US$2,176,530 		300,000 +0.5% 7.26 US$2,176,530
2022-05-16 2022-05-12 B Purchase
4.1
Booth Andrew

Chief Financial Officer

Officer
85,000 +158.9%
5.79
US$492,150 		85,000 +158.9% 5.79 US$492,150
2022-05-16 2022-05-12 B Purchase
4.3
Thermopylae Holdings Ltd.
Large shareholder
1,408,468 +2.6%
6.41
US$9,021,801 		1,408,468 +2.6% 6.41 US$9,021,801
2022-03-04 2022-03-04 B Purchase
3.3
Montalbano John S.
Non-Executive Director
10,000 +21.7%
8.54
US$85,400 		10,000 +21.7% 8.54 US$85,400
2022-03-03 2022-03-01 B Purchase
3.3
Montalbano John S.
Non-Executive Director
20,000 +76.9%
9.05
US$181,000 		20,000 +76.9% 9.05 US$181,000
2022-03-01 2022-02-28 B Purchase
3.9
Lecault Veronique

Chief Operating Officer

Executive Director
230,789 +17.2%
8.66
US$1,998,633 		230,789 +17.2% 8.66 US$1,998,633
2021-12-07 2021-12-03 B Purchase
2.5
Lo Andrew
Non-Executive Director
86,938 +inf%
14.02
US$1,218,871 		86,938 +inf% 14.02 US$1,218,871
2021-11-15 2021-11-11 B Purchase
4.3
Thermopylae Holdings Ltd.
Large shareholder
202,960 +0.4%
14.76
US$2,995,913 		202,960 +0.4% 14.76 US$2,995,913
2021-11-15 2021-11-11 B Purchase
4.1
Booth Andrew

Chief Financial Officer

Officer
14,000 +12.0%
14.61
US$204,540 		14,000 +12.0% 14.61 US$204,540
2021-11-15 2021-11-11 B Purchase
4.1
Booth Andrew

Chief Financial Officer

Officer
53,500 +inf%
14.74
US$788,590 		53,500 +inf% 14.74 US$788,590
2021-06-22 2021-06-22 S Sale
3.1
Hayden Michael R
Non-Executive Director
100,000 -9.1%
25.50
US$2,550,000 		100,000 -9.1% 25.50 US$2,550,000
2021-06-10 2021-06-09 S Sale
4.1
Booth Andrew

Chief Financial Officer

Officer
1,200,000 -100.0%
25.50
US$30,600,000 		1,200,000 -100.0% 25.50 US$30,600,000
2021-06-10 2021-06-09 S Sale
3.3
Hansen Carl L. G.

Chief Executive Officer

Executive Director Large shareholder
401,580 -63.2%
25.50
US$10,240,290 		401,580 -63.2% 25.50 US$10,240,290
2021-06-10 2021-06-09 S Sale
3.3
Hansen Carl L. G.

Chief Executive Officer

Executive Director Large shareholder
5,598,420 -9.1%
24.03
US$134,530,033 		5,598,420 -9.1% 24.03 US$134,530,033
2021-06-10 2021-06-09 S Sale
3.3
Stimart Tryn

Chief Legal Officer

Officer
1,000,000 -100.0%
25.50
US$25,500,000 		1,000,000 -100.0% 25.50 US$25,500,000
2021-06-10 2021-06-09 S Sale
3.9
Lecault Veronique

Chief Operating Officer

Executive Director
1,000,000 -78.5%
25.50
US$25,500,000 		1,000,000 -78.5% 25.50 US$25,500,000
2021-06-10 2021-06-09 S Sale
4.3
Thermopylae Holdings Ltd.
Large shareholder
5,598,420 -9.1%
24.03
US$134,530,033 		5,598,420 -9.1% 24.03 US$134,530,033
2021-06-10 2021-06-09 S Sale
3.3
Falconer Ester

Chief Technology Officer

Officer
1,000,000 -100.0%
25.50
US$25,500,000 		1,000,000 -100.0% 25.50 US$25,500,000
2020-12-17 2020-12-15 B Purchase
1.3
THIEL PETER
Non-Executive Director
3,000,000 +41.8%
20.00
US$60,000,000 		3,000,000 +41.8% 20.00 US$60,000,000
2020-12-17 2020-12-15 B Purchase
3.9
Lecault Veronique

Chief Operating Officer

Executive Director
17,000 +38.1%
20.00
US$340,000 		17,000 +38.1% 20.00 US$340,000
2020-12-17 2020-12-15 B Purchase
3.3
Stimart Tryn

Chief Legal Officer

Officer
250 +inf%
20.00
US$5,000 		250 +inf% 20.00 US$5,000
2020-12-17 2020-12-15 B Purchase
3.3
Montalbano John S.
Non-Executive Director
5,000 +inf%
20.00
US$100,000 		5,000 +inf% 20.00 US$100,000
2020-12-17 2020-12-15 B Purchase
3.1
Hayden Michael R
Non-Executive Director
73,665 +165.2%
20.00
US$1,473,300 		73,665 +165.2% 20.00 US$1,473,300
2020-12-17 2020-12-15 B Purchase
3.9
Lecault Veronique

Chief Operating Officer

Executive Director
6,000 +0.6%
20.00
US$120,000 		6,000 +0.6% 20.00 US$120,000
2020-12-17 2020-12-15 B Purchase
3.3
Stimart Tryn

Chief Legal Officer

Officer
250 +inf%
20.00
US$5,000 		250 +inf% 20.00 US$5,000
2020-12-17 2020-12-15 B Purchase
3.3
Montalbano John S.
Non-Executive Director
20,000 +inf%
20.00
US$400,000 		20,000 +inf% 20.00 US$400,000
Explore more

More insider trading research around Abcellera Biologics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America